(Q43105772)

English

Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

scientific article published on 6 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

adaptive radiation therapy

0 references

gastrointestinal carcinoma

1 reference

based on heuristic

inferred from title

Kjersti Flatmark

8

object named as

Kjersti Flatmark

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Anne Hansen Ree

1

object named as

Anne Hansen Ree

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

2

object named as

Svein Dueland

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Therese Seierstad

5

object named as

Therese Seierstad

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sigurd Folkvord

3

object named as

Sigurd Folkvord

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Torveig W Abrahamsen

7

object named as

Torveig W Abrahamsen

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

Knut H Hole

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Marianne Johansen

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

6 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

459-464

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Cell-cycle checkpoints and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the DNA damage response in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular targets for tumor radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel targeted radiosensitisers in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of histone deacetylation: a strategy for tumor radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vorinostat in solid and hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HDAC2 deficiency and histone acetylation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diffusion MRI for prediction of response of rectal cancer to chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel designs and end points for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical studies of histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A work in progress: the clinical development of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970058-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70058-9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43105772&oldid=1980871316"